Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa

被引：32

作者：

Kim, Doo-Jin ^{[1
,2
]}

Kim, Kwang-Soon ^{[3
]}

Song, Mi-Young ^{[3
]}

Seo, Sang-Hwan ^{[2
]}

Kim, Su-Jin ^{[2
]}

Yang, Bo-Gie ^{[3
]}

Jang, Myoung-Ho ^{[3
,4
]}

Sung, Young-Chul ^{[3
]}

机构：

[1] KRIBB, Viral Infect Dis Res Ctr, Taejon 305806, South Korea

[2] POSTECH, Div Mol & Life Sci, Pohang 790784, South Korea

[3] POSTECH, WCU, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea

[4] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan

来源：

CLINICAL IMMUNOLOGY | 2012年 / 144卷 / 03期

基金：

新加坡国家研究基金会;

关键词：

IL-12p40; DSS-induced colitis; Inflammatory bowel disease (IBD); IL-17A; MESENCHYMAL STEM-CELLS; SODIUM-INDUCED COLITIS; SEVERE CROHNS-DISEASE; TNBS-INDUCED COLITIS; CD4(+) T-CELLS; BOWEL-DISEASE; P40; HOMODIMER; STIMULATORY FACTOR; INTERFERON-GAMMA; MICE;

D O I：

10.1016/j.clim.2012.06.009

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

IL-12p40 homodimer is a natural antagonist of IL-12 and IL-23, which are potent pro-inflammatory cytokines required for Th1 and Th17 immune responses, respectively. It has been reported that Th17 response is involved in inflammatory bowel disease (IBD), a chronic disorder of the digestive system with steadily increasing incidence. Here, we investigated the effects of IL-12p40 delivered via recombinant adenovirus (rAd/IL-12p40) or mesenchymal stem cells (MSC/IL-12p40) in a dextran sulfate sodium salt (DSS)-induced colitis model. Injection of rAd/IL-12p40 or MSC/IL-12p40 efficiently attenuated colitis symptoms and tissue damage, Leading to an increased survival rate. Moreover, IL-12p40 delivery suppressed IL-17A, but enhanced IFN-gamma production from mesenteric lymph node cells, supporting the preferential suppression of IL-23 by IL-12p40 homodimer in vitro and the suppression of Th17 responses in vivo. Our results demonstrate that IL-12p40 delivery ameliorates DSS-induced colitis by suppressing IL-17A production and inflammation in the intestinal mucosa, providing an effective new therapeutic strategy for IBDs. (c) 2012 Elsevier Inc. All rights reserved.

引用

页码：190 / 199

页数：10

共 51 条

[31] Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 [J].

Oppmann, B ;

Lesley, R ;

Blom, B ;

Timans, JC ;

Xu, YM ;

Hunte, B ;

Vega, F ;

Yu, N ;

Wang, J ;

Singh, K ;

Zonin, F ;

Vaisberg, E ;

Churakova, T ;

Liu, MR ;

Gorman, D ;

Wagner, J ;

Zurawski, S ;

Liu, YJ ;

Abrams, JS ;

Moore, KW ;

Rennick, D ;

de Waal-Malefyt, R ;

Hannum, C ;

Bazan, JF ;

Kastelein, RA .

IMMUNITY, 2000, 13 (05) :715-725

[32] Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells [J].

Park, S-H ;

Doh, J. ;

Park, S. I. ;

Lim, J. Y. ;

Kim, S. M. ;

Youn, J-I ;

Jin, H-T ;

Seo, S-H ;

Song, M-Y ;

Sung, S. Y. ;

Kim, M. ;

Hwang, S. J. ;

Choi, J-M ;

Lee, S-K ;

Lee, H. Y. ;

Lim, C. L. ;

Chung, Y. J. ;

Yang, D. ;

Kim, H-N ;

Lee, Z. H. ;

Choi, K. Y. ;

Jeun, S-S ;

Sung, Y. C. .

GENE THERAPY, 2010, 17 (08) :1052-1061

[33] Therapeutic Effects of Novel Sphingosine-1-Phosphate Receptor Agonist W-061 in Murine DSS Colitis [J].

Sanada, Yasuaki ;

Mizushima, Tsunekazu ;

Kai, Yasuyuki ;

Nishimura, Junichi ;

Hagiya, Hiroshi ;

Kurata, Haruto ;

Mizuno, Hirotaka ;

Uejima, Etsuko ;

Ito, Toshinori .

PLOS ONE, 2011, 6 (09)

[34] A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease [J].

Sandborn, William J. ;

Feagan, Brian G. ;

Fedorak, Richard N. ;

Scherl, Ellen ;

Fleisher, Mark R. ;

Katz, Seymour ;

Johanns, Jewel ;

Blank, Marion ;

Rutgeerts, Paul .

GASTROENTEROLOGY, 2008, 135 (04) :1130-1141

[35] Biologics in inflammatory bowel disease: how much progress have we made? [J].

Sandborn, WJ ;

Faubion, WA .

GUT, 2004, 53 (09) :1366-1373

[36]

SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433

[37] The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity [J].

Seo, S. H. ;

Kim, K. S. ;

Park, S. H. ;

Suh, Y. S. ;

Kim, S. J. ;

Jeun, S-S ;

Sung, Y. C. .

GENE THERAPY, 2011, 18 (05) :488-495

[38] The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects [J].

Shimozato, O ;

Ugai, S ;

Chiyo, M ;

Takenobu, H ;

Nagakawa, H ;

Wada, A ;

Kawamura, K ;

Yamamoto, H ;

Tagawa, M .

IMMUNOLOGY, 2006, 117 (01) :22-28

[39] Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action [J].

Shintani, N ;

Nakajima, T ;

Okamoto, T ;

Kondo, T ;

Nakamura, N ;

Mayumi, T .

GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1998, 31 (03) :477-481

[40] Activation of Aryl Hydrocarbon Receptor (AhR) Leads to Reciprocal Epigenetic Regulation of FoxP3 and IL-17 Expression and Amelioration of Experimental Colitis [J].

Singh, Narendra P. ;

Singh, Udai P. ;

Singh, Balwan ;

Price, Robert L. ;

Nagarkatti, Mitzi ;

Nagarkatti, Prakash S. .

PLOS ONE, 2011, 6 (08)

← 1 2 3 4 5 6 →